Literature DB >> 17124404

Molecular karyotyping of patients with MCA/MR: the blurred boundary between normal and pathogenic variation.

T J L de Ravel1, I Balikova, B Thienpont, F Hannes, N Maas, J-P Fryns, K Devriendt, J R Vermeesch.   

Abstract

Molecular karyotyping has revealed that microdeletions/duplications in the human genome are a major cause of multiple congenital anomalies associated with mental retardation (MCA/MR). The identification of a de novo chromosomal imbalance in a patient with MCA/MR is usually considered causal for the phenotype while a chromosomal imbalance inherited from a phenotypically normal parent is considered as a benign variation and not related to the disorder. Around 40% of imbalances in patients with MCA/MR in this series is inherited from a healthy parent and the majority of these appear to be (extremely) rare variants. As some of these contain known disease-causing genes and have also been found to be de novo in MCA/MR patients, this challenges the general view that such familial variants are innocent and of no major phenotypic consequence. Rather, we argue, that human genomes can be tolerant of genomic copy number variations depending on the genetic and environmental background and that different mechanisms play a role in determining whether these chromosomal imbalances manifest themselves. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 17124404     DOI: 10.1159/000095918

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  7 in total

1.  Practical guidelines for interpreting copy number gains detected by high-resolution array in routine diagnostics.

Authors:  Nicolien M Hanemaaijer; Birgit Sikkema-Raddatz; Gerben van der Vries; Trijnie Dijkhuizen; Roel Hordijk; Anthonie J van Essen; Hermine E Veenstra-Knol; Wilhelmina S Kerstjens-Frederikse; Johanna C Herkert; Erica H Gerkes; Lamberta K Leegte; Klaas Kok; Richard J Sinke; Conny M A van Ravenswaaij-Arts
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

2.  Molecular karyotyping in patients with mental retardation using 100K single-nucleotide polymorphism arrays.

Authors:  Juliane Hoyer; Alexander Dreweke; Christian Becker; Ina Göhring; Christian T Thiel; Maarit M Peippo; Ralf Rauch; Michael Hofbeck; Udo Trautmann; Christiane Zweier; Martin Zenker; Ulrike Hüffmeier; Cornelia Kraus; Arif B Ekici; Franz Rüschendorf; Peter Nürnberg; André Reis; Anita Rauch
Journal:  J Med Genet       Date:  2007-06-29       Impact factor: 6.318

Review 3.  What's new in karyotyping? The move towards array comparative genomic hybridisation (CGH).

Authors:  Thomy J L de Ravel; Koen Devriendt; Jean-Pierre Fryns; Joris R Vermeesch
Journal:  Eur J Pediatr       Date:  2007-03-20       Impact factor: 3.183

4.  Benign copy number changes in clinical cytogenetic diagnostics by array CGH.

Authors:  H Whitby; A Tsalenko; E Aston; P Tsang; S Mitchell; P Bayrak-Toydemir; C Hopkins; G Peters; D K Bailey; L Bruhn; A R Brothman
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

5.  A new diagnostic workflow for patients with mental retardation and/or multiple congenital abnormalities: test arrays first.

Authors:  Antoinet C J Gijsbers; Janet Y K Lew; Cathy A J Bosch; Janneke H M Schuurs-Hoeijmakers; Arie van Haeringen; Nicolette S den Hollander; Sarina G Kant; Emilia K Bijlsma; Martijn H Breuning; Egbert Bakker; Claudia A L Ruivenkamp
Journal:  Eur J Hum Genet       Date:  2009-05-13       Impact factor: 4.246

6.  Medical conditions in autism spectrum disorders.

Authors:  Patrick F Bolton
Journal:  J Neurodev Disord       Date:  2009-07-07       Impact factor: 4.025

7.  A Multicentric Brazilian Investigative Study of Copy Number Variations in Patients with Congenital Anomalies and Intellectual Disability.

Authors:  J R M Ceroni; R L Dutra; R S Honjo; J C Llerena; A X Acosta; P F V Medeiros; M F Galera; É A Zanardo; F B Piazzon; A T Dias; G M Novo-Filho; M M Montenegro; F A R Madia; D R Bertola; J B de Melo; L D Kulikowski; C A Kim
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.